bluebird bio Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
BLUE Nasdaq 8731 https://www.bluebirdbio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for bluebird bio Inc

Why Bluebird Bio Stock Is Sinking This Week - Mar 30th, 2023 5:54 pm
Bluebird Bio (BLUE) Reports Q4 Loss, Misses Revenue Estimates - Mar 29th, 2023 12:15 pm
bluebird bio Reports Fourth Quarter and Full Year 2022 Financial Results and Highlights Operational Progress - Mar 29th, 2023 11:00 am
Bluebird Bio (BLUE) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Feb 24th, 2023 3:00 pm
1 Beaten-Down Stock That Has a Lot to Prove in 2023 - Feb 8th, 2023 1:05 pm
Here's why 2seventy bio's chief executive thinks 2023 will be a 'special year' - Feb 3rd, 2023 10:00 am
bluebird bio, Inc. (NASDAQ:BLUE) is favoured by institutional owners who hold 58% of the company - Jan 30th, 2023 2:12 pm
Zacks.com featured highlights include bluebird bio, Pros Holdings and Norwegian Cruise Line - Jan 24th, 2023 1:58 pm
Better Biotech Buy: Bluebird Bio or CRISPR Therapeutics? - Jan 22nd, 2023 2:00 pm
bluebird bio, Inc. Announces Pricing of $120 Million Public Offering of Common Stock - Jan 19th, 2023 1:00 am
Moderna Gets Good News, but Another Biotech Stock Is Falling Again - Jan 18th, 2023 2:12 pm
bluebird bio, Inc. Announces Proposed Public Offering of Common Stock - Jan 18th, 2023 11:43 am
bluebird bio Provides Update on Commercial Launch Progress, Program Milestones and 2023 Financial Outlook Ahead of Company Presentation at 41st Annual J.P. Morgan Healthcare Conference - Jan 9th, 2023 12:00 pm
2 Stocks That Could Double Your Money in 2023 - Jan 7th, 2023 3:07 pm
bluebird bio Sells Second Priority Review Voucher for $95 Million - Jan 6th, 2023 12:30 pm
Newly Approved Drugs In US Command Over $200,000 On An Average - Jan 5th, 2023 6:13 pm
bluebird bio to Present at the 41st Annual J.P. Morgan Healthcare Conference - Jan 5th, 2023 1:00 pm
bluebird bio Appoints Joseph Vittiglio, JD, as Chief Business and Legal Officer - Jan 3rd, 2023 1:00 pm
15 Most Shorted Stocks Hedge Funds Are Buying - Dec 28th, 2022 5:32 pm
After Doubling in the Past 6 Months, Is This Stock a Buy? - Dec 24th, 2022 1:07 pm